If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
487.60    4.80 (0.99%)
Bid:
487.00
Ask:
487.60
Spread: 0.60 (0.123%)
Market Cap: £2.50b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

£80m contract win with UK MOD

16 Jan 2023 07:00

RNS Number : 7531M
QinetiQ Group plc
16 January 2023
 

News release

QinetiQ Group Plc

£80m contract win with UK MOD

16 January 2023 - QinetiQ Group plc ("QinetiQ" or the "Company") is pleased to announce that it has won an £80m contract with the UK's Ministry of Defence (MOD).  The contract will provide expertise, training and support to accelerate and transform mission data production; this will enable military platforms and personnel, from the UK and its allies, to be better protected in a rapidly changing threat landscape and enhance the performance of our advanced military systems.

 

We will work in partnership with the MOD for a 10-year period on the transformation project, providing a specialist mission data and electronic warfare skills solution alongside training and IT support. This win is a great example of our cyber and information advantage distinctive offering and the strength of our partnering across industry, bringing together extensive experience of electronic warfare, mission data analysis, communication and information services and data-led transformation to achieve operational advantage over our adversaries.

 

James Willis, Chief Executive of UK Intelligence at QinetiQ said:

 

"We are delighted to be selected as the MoD's Industry Partner for mission data. The contract demonstrates how the MoD works closely with industry to build the skills of the future and introduce innovative approaches to enhance mission capability. Our team is harnessing the value delivered by small and medium sized companies and our academic partners. We look forward to working together in partnership with the MoD delivering the next generation of mission data."

 

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Lorna Cobbett, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7771 344781

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDBGDBGXBDGXU
Date   Source Headline
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
24th Jul 20172:31 pmRNSDirector/PDMR Shareholding
21st Jul 201711:18 amRNSDirector/PDMR Shareholding
19th Jul 20174:05 pmRNSAGM Statement
19th Jul 20177:00 amRNSFirst Quarter Trading Update
13th Jul 20173:30 pmRNSDirector/PDMR Shareholding
11th Jul 20174:15 pmRNSDirector/PDMR Shareholding
7th Jul 20174:13 pmRNSAnnual Financial Report
23rd Jun 20179:40 amRNSDirector/PDMR Shareholding
21st Jun 20175:08 pmRNSDirector/PDMR Shareholding
13th Jun 20173:55 pmRNSAnnual Financial Report
12th Jun 20172:56 pmRNSDirector/PDMR Shareholding
25th May 20177:00 amRNSFull Year Results 2017
10th May 20174:00 pmRNSDirector/PDMR Shareholding
5th May 20174:42 pmRNSBlock listing Interim Review
12th Apr 20174:12 pmRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSTotal Voting Rights
28th Mar 20171:47 pmRNSTransaction in Own Shares 27 Mar 17 - Replacement
27th Mar 20175:48 pmRNSTransaction in Own Shares
24th Mar 20175:13 pmRNSTransaction in Own Shares
23rd Mar 20175:34 pmRNSTransaction in Own Shares
22nd Mar 20175:45 pmRNSTransaction in Own Shares
21st Mar 20175:31 pmRNSTransaction in Own Shares
20th Mar 20175:18 pmRNSTransaction in Own Shares
17th Mar 20175:53 pmRNSTransaction in Own Shares
16th Mar 20175:49 pmRNSTransaction in Own Shares
10th Mar 20173:17 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
27th Feb 20175:01 pmRNSTransaction in Own Shares
24th Feb 20175:09 pmRNSTransaction in Own Shares
23rd Feb 20175:08 pmRNSTransaction in Own Shares
22nd Feb 20175:20 pmRNSTransaction in Own Shares
21st Feb 20175:12 pmRNSTransaction in Own Shares
15th Feb 20177:00 amRNSThird Quarter Trading Update
13th Feb 20173:00 pmRNSDirector/PDMR Shareholding
10th Feb 20171:51 pmRNSDirector/PDMR Shareholding
31st Jan 20175:06 pmRNSTransaction in Own Shares
31st Jan 201711:00 amRNSTotal Voting Rights
30th Jan 20175:19 pmRNSTransaction in Own Shares
27th Jan 20175:05 pmRNSTransaction in Own Shares
26th Jan 20175:08 pmRNSTransaction in Own Shares
26th Jan 20178:00 amRNSChange of Auditor
25th Jan 20175:19 pmRNSTransaction in Own Shares
24th Jan 20175:22 pmRNSTransaction in Own Shares
16th Jan 20174:17 pmRNSDirector/PDMR Shareholding
10th Jan 20174:04 pmRNSDirector/PDMR Shareholding
6th Jan 20179:47 amRNSConfirmation of Date of Appointment of CFO
21st Dec 20167:00 amRNSQinetiQ acquires Meggitt Target Systems
12th Dec 20164:11 pmRNSDirector/PDMR Shareholding
12th Dec 20164:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.